Remission in SLE: closing in on the target
Ann Rheum Dis
.
2015 Dec;74(12):2103-6.
doi: 10.1136/annrheumdis-2015-208231.
Epub 2015 Oct 28.
Authors
Ronald F van Vollenhoven
1
,
Alexandre Voskuyl
2
,
Eric Morand
3
,
Cynthia Aranow
4
Affiliations
1
Department of Medicine, The Karolinska Institute, Stockholm, Sweden.
2
Department of Rheumatology, Amsterdam Rheumatology and Immunology Center ARC, Amsterdam, The Netherlands.
3
School of Clinical Sciences, Monash University, Clayton, Victoria, Australia.
4
Center for Autoimmune and Musculoskeletal, The Feinstein Institute for Medical Research, Manhasset, New York, USA.
PMID:
26511997
DOI:
10.1136/annrheumdis-2015-208231
No abstract available
Keywords:
Outcomes research; Systemic Lupus Erythematosus; Treatment.
Publication types
Editorial
Comment
MeSH terms
Female
Humans
Lupus Erythematosus, Systemic / drug therapy*
Male
White People*